On December 27, 2024, FOSUN PHARMA (Group) Co., Ltd. repurchased 204,500 H shares on the Hong Kong Stock Exchange as treasury shares. The repurchase price range was from HKD 13.94 to HKD 14.1 per share, with a total value of approximately HKD 2.8723 million.This repurchase accounts for 0.04% of the total number of H shares of the company. After the buyback, the total number of H shares remains unchanged at 551,940,500 shares, but the number of issued shares (excluding treasury shares) decreased to 544,910,500 shares, and the number of treasury shares increased to 7,030,000 shares.Since the approval of the repurchase authorization by the shareholder meeting, the company has cumulatively repurchased approximately 1.27% of the H shares. According to regulations, the company is not allowed to issue new shares or sell or transfer treasury shares within 30 days after this repurchase (until January 26, 2025).

On December 27, 2024, FOSUN PHARMA (Group) Co., Ltd. repurchased 204,500 H shares on the Hong Kong Stock Exchange as treasury shares. The repurchase price range was from HKD 13.94 to HKD 14.1 per share, with a total value of approximately HKD 2.8723 million.This repurchase accounts for 0.04% of the total number of H shares of the company. After the buyback, the total number of H shares remains unchanged at 551,940,500 shares, but the number of issued shares (excluding treasury shares) decreased to 544,910,500 shares, and the number of treasury shares increased to 7,030,000 shares.Since the approval of the repurchase authorization by the shareholder meeting, the company has cumulatively repurchased approximately 1.27% of the H shares. According to regulations, the company is not allowed to issue new shares or sell or transfer treasury shares within 30 days after this repurchase (until January 26, 2025).